ABLYNX KONDIGT WIJZIGING IN RAAD VAN BESTUUR AAN
January 08, 2018 11:32 ET
|
Ablynx NV
8 januari 2018 - 17u30 Belgische tijd GENT, België, 8 januari 2018 (17u30 Belgische tijd) - Ablynx NV [Euronext Brussels en Nasdaq: ABLX] deelde vandaag mee dat Dr Peter Fellner, die het mandaat...
ABLYNX ANNOUNCES BOARD CHANGES
January 08, 2018 11:32 ET
|
Ablynx NV
8 January 2018 - 5:30 pm CET GHENT, Belgium, 8 January 2018 (5:30 pm CET) - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced that Dr Peter Fellner, who has served as Chairman since...
Orphazyme assumes sponsorship of Phase II/III sIBM trial
December 15, 2017 09:20 ET
|
ORPHAZYME A/S
Investor newsNo. 01/2017 Orphazyme assumes sponsorship of Phase II/III sIBM trial On December 14, 2017, Orphazyme A/S, University of Kansas Medical Center, and UCL announced that Orphazyme...
ORPHAZYME COMPLETES ENROLMENT OF PATIENTS FOR PHASE 3 CLINICAL TRIAL IN NIEMANN-PICK TYPE C DISEASE
May 11, 2017 08:28 ET
|
Orphazyme ApS
Copenhagen, 11 May 2017 Orphazyme ApS, a Danish biotech company developing novel therapies for the treatment of protein misfolding diseases, today announced the completion of enrolment for its...
ORPHAZYME COMPLETES ENROLMENT OF PATIENTS FOR PHASE 3 CLINICAL TRIAL IN NIEMANN-PICK TYPE C DISEASE
May 11, 2017 08:07 ET
|
Orphazyme ApS
Copenhagen, 11 May 2017 Orphazyme ApS, a Danish biotech company developing novel therapies for the treatment of protein misfolding diseases, today announced the completion of enrolment for its lead...
JLM Energy debuts exclusive product features at Intersolar with partner Fronius
July 13, 2016 12:06 ET
|
JLM Energy
SAN FRANCISCO, July 13, 2016 (GLOBE NEWSWIRE) -- Today JLM Energy Founder and CEO Farid Dibachi, debuted exclusive features of the Energizr 200 grid synergistic renewable energy PLUS storage ecosystem...
Elite Pharmaceuticals to Present SequestOx™ Data at the American Pain Society 35th Annual Scientific Meeting
May 09, 2016 07:30 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today it will present data for SequestOx™ (ELI-200) at the American...
Georges Gemayel, Ph.D., Joins Supernus Board of Directors
March 23, 2015 17:00 ET
|
Supernus Pharmaceuticals, Inc.
ROCKVILLE, Md., March 23, 2015 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Two Upcoming Scientific Conferences
May 01, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...
Topotarget A/S indleder strategisk gennemgang og ændrer direktionen
August 30, 2012 04:06 ET
|
Topotarget
Til NASDAQ OMX Copenhagen A/S
Meddelelse Nr. 14-12 / København, 30. august 2012
København, Danmark – 30. august 2012 – Topotarget A/S (NASDAQ OMX: TOPO) har i dag annonceret indledningen af en...